Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Bupivacaine Liposome Combined With Bupivacaine Hydrochloride on Thoracic Paravertebral Nerve Block for Postoperative Pain After Thoracoscopic Lung Surgery

NCT06165991 is registered in ClinicalTrials.gov with Yongtao Sun as lead sponsor.

NCT NCT06165991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06165991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Bupivacaine Liposome Combined With Bupivacaine Hydrochloride on Thoracic Paravertebral Nerve Block for Postoperative Pain After Thoracoscopic Lung Surgery
Lead sponsor
Yongtao Sun
Phase
Phase 4
Overall status
Recruiting
Start date
June 1, 2024
Completion date
January 31, 2026
Enrollment
496 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postoperative analgesia, thoracic paravertebral block, thoracoscopic lobectomy